CHIARAMONTE, ELOISA

CHIARAMONTE, ELOISA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 16 di 16 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Primary TSC2-/meth Cells Induce Follicular Neogenesis in an Innovative TSC Mouse Model 2022 Clara BernardelliEloisa ChiaramonteSilvia AnconaSilvia M. SirchiaAmilcare CerriElena Lesma Article (author) -
Differential modulation of matrix metalloproteinases-2 and-7 in LAM/TSC cells 2021 Ancona S.Orpianesi E.Bernardelli C.Chiaramonte E.Chiaramonte R.Terraneo S.Di Marco F.Lesma E. Article (author) -
Anti-EGFR antibody reduces lung nodules by inhibition of EGFR-pathway in a model of lymphangioleiomyomatosis 2015 E. LesmaE. ChiaramonteS. AnconaE. OrpianesiA.M. Di GiulioA. Gorio Article (author) -
TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival 2014 E. LesmaS. AnconaS.M. SirchiaE. OrpianesiV. GrandeP. ColapietroE. ChiaramonteA.M. Di GiulioA. Gorio Article (author) -
LAM/TSC cell migration to uterus in an experimental model of lymphangioleiomyomatosis. Regulation by anti-epidermal growth factor receptor antibody and rapamycin 2014 E. LesmaE. ChiaramonteS. AnconaA.M. Di GiulioA. Gorio Article (author) -
Development of a lymphangioleiomyomatosis model by endonasal administration of human TSC2-/- smooth muscle cells in mice 2012 E. LesmaE. ChiaramonteS. AnconaE. OrpianesiA.M. Di GiulioA. Gorio + Article (author) -
ALTERAZIONI ISTOPATOLOGICHE INDOTTE DA CELLULE UMANE LAM/TSC IN TOPI NUDI: UN MODELLO DI LINFANGIOLEIOMIOMATOSI. REVERSIONE DEL DANNO CON ANTICORPO ANTI-EGFR 2012 E. Chiaramonte Doctoral Thesis -
A mouse LAM model by endonasal administration of human TSC2 deficient smooth muscle cells 2010 E. LesmaE. ChiaramonteS. AnconaV. GrandeA.M. Di GiulioA. Gorio Article (author) -
Development of a LAM model by using human TSC2 deficient smooth muscle cells derived from a renal angiomylipoma 2010 E. LesmaE. ChiaramonteV. GrandeS. AnconaA.M. Di GiulioA. Gorio Conference Object -
Un modello di linfangioleiomiomatosi con la somministrazione di cellule muscolari lisce umane TSC2-/- 2010 E. LesmaE. ChiaramonteV. GrandeS. AnconaF. La BriolaM.P. CaneviniCORONA, MASSIMILIANOF. GhelmaA.M. Di GiulioA. Gorio Conference Object -
Characterization of LAM/TSC cells isolated from patient chylous 2010 E. LesmaS. AnconaV. GrandeS.M. SirchiaE. ChiaramonteS. BosariA.M. Di GiulioA. Gorio Conference Object -
Pathogenesis and pharmacological evaluation of human TSC2 smooth muscle cells. Possible treatment options for TSC and lymphangioleiomyomatosis 2009 E. LesmaV. GrandeS. AnconaE. ChiaramonteS. M. SirchiaA. M. Di GiulioA. Gorio Conference Object -
Human smooth muscle TSC2-/- cells cause lymphangiogenesis-like lung destruction in nude mice. Pharmacological repair 2009 E. LesmaE. ChiaramonteS. AnconaV. GrandeR. AdamiA.M. Di GiulioA. Gorio Conference Object -
Promoter methylation of TSC2 gene is important for pathogenesis of TSC and LAM lesions 2009 S. AnconaE. LesmaS.M. SirchiaV. GrandeE. ChiaramonteA.M. Di GiulioA. Gorio Conference Object -
Role of HMG-CoA reductase inhibitors in controlling TSC2-/- ASM cell growth and proliferation 2009 V. GrandeE. LesmaS. AnconaE. ChiaramonteA.M. Di GiulioA. Gorio Conference Object -
An epigenetic event may underlies the TSC features in TSC2 ASM cells 2009 E. LesmaS. AnconaS.M. SirchiaV. GrandeE. ChiaramonteS. BosariA.M. Di GiulioA. Gorio Conference Object -